Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial

Dig Liver Dis. 2020 Nov;52(11):1254-1256. doi: 10.1016/j.dld.2020.09.012. Epub 2020 Sep 19.

Authors

Anuraag Jena¹, Anupam Kumar Singh¹, Praveen Kumar-M², Vishal Sharma³, Shaji Sebastian⁴

Affiliations

¹ Department of Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
² Pharmacology, Postgraduate Institute of Medical Education & Research, India.
³ Department of Gastroenterology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. Electronic address: [email protected].
⁴ Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom. Electronic address: [email protected].

No abstract available

Publication types

Letter
Systematic Review

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections
Health Services Accessibility
Humans
Inflammatory Bowel Diseases / drug therapy*
Pandemics
Pneumonia, Viral
SARS-CoV-2
Treatment Adherence and Compliance / statistics & numerical data*